Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis. Article uri icon

Overview

publication date

  • September 1, 2024

Research

keywords

  • Antibodies, Monoclonal
  • Lymphohistiocytosis, Hemophagocytic
  • Salvage Therapy

Identity

PubMed Central ID

  • PMC11367207

Scopus Document Identifier

  • 85203029399

Digital Object Identifier (DOI)

  • 10.3324/haematol.2023.284179

PubMed ID

  • 38752279

Additional Document Info

volume

  • 109

issue

  • 9